- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04104516
Lifestyle Modification Program for Lung Cancer Patients - Physical Activity Preference
A Brief Messaging Lifestyle Modification Program for Patients With Non-small Cell Lung Cancer
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Lung cancer is one of the most common cancer globally and locally. Patients with lung cancer are in a uniquely difficult situation in their disease, comorbidities, and treatment that may lead to worsened symptoms and many negative health consequences, including fatigue, irritability, and impaired daytime functioning.
Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that results in energy expenditure'. Several health benefits of increased PA have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. However, most of the findings were predominantly in breast and colorectal cancers. The PA dosage required to attain health benefits across these cancer groups is not uniform, nor is it clear whether the results can be applied to other groups of people with cancer.
The current study includes a cross-sectional questionnaire survey and an in-depth interview. It aims to understand the current physical activity practice and preference of patients with lung cancer, which could help to develop a lifestyle modification program based on our patients' needs and preferences.
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studie Locaties
-
-
-
Hong Kong, Hongkong
- Werving
- Queen Mary Hospital
-
Contact:
- Agnes YK Lai, PhD
- Telefoonnummer: 852-3917-6328
- E-mail: agneslai@hku.hk
-
Contact:
- Mary MS Ip, MD
- Telefoonnummer: 852-2255-4455
- E-mail: msmip@hku.hk
-
Hoofdonderzoeker:
- Agnes y Lai, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Aged 18 years and above;
- Diagnosis with non-small cell lung cancer
- General condition stable, either is undergoing or finished treatment
- Able to speak and read Chinese
- Able to complete the self-administered questionnaire
- Mental, cognitive and physically fit for joining the trial as determined by the clinician or responsible investigator
Exclusion Criteria:
- Mentally unfit for answering questionnaire
- Unable to give informed consent
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Preference on physical activity program
Tijdsspanne: immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
immediately after obtaining written consent
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Current physical activity practise
Tijdsspanne: immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
immediately after obtaining written consent
|
|
Preference on information to be received
Tijdsspanne: immediately after obtaining written consent
|
Outcome-based questions with categorical choices
|
immediately after obtaining written consent
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: LAI YK Agnes, PhD, School of Nursing, The University of Hong Kong
Publicaties en nuttige links
Algemene publicaties
- Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985 Mar-Apr;100(2):126-31.
- Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvao DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2.
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- UW19-597-1
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .